EFNB1 and neoplasm: In addition, Vermeer et al. found that EFNB1, as a PTPN13 phosphatase substrate, and its mobilization were related to ERK1/2 phosphorylation and its complex with ERBB2 mediated signal transduction and drug resistance in tumor cells [14].